The Board of Directors at its meeting held on 05.11.2026 approved the allotment of 7,86,690 Equity Shares to the Promoter Category on conversion of warrants, upon receipt of the balance amount. Details are enclosed.

GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com Date: 05.11.2026 BSE Limited, P.J. Towers, Dalal Street, Mumbai – 400001 Dear Sir/Madam Unit: Godavari Drugs Limited (Scrip Code: 530317) Sub: Outcome of Board Meeting held on 05.11.2026 With reference to the subject cited this is to inform the Exchange that the Board of Directors of Godavari Drugs Limited, at its Meeting held on Thursday, 05th November, 2026, at 5:30 p.m. at the registered office of the Company, considered and approved the allotment of Equity Shares on conversion of 7,86,690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) warrants into 7,86,690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) Equity Shares at an issue price of Rs. 89/- each (including a premium of Rs. 79/- each), to “Promoters Category”, on preferential basis, upon receipt of balance amount aggregating to Rs. 5,25,11,557.50/- (Rupees Five Crores Twenty-Five Lakhs Eleven Thousand Five Hundred and Fifty-Seven and Fifty Paise Only) being 75% of the issue price per warrant, from the allottees pursuant to the exercise of their rights of conversion into equity shares in accordance with the provisions of SEBI (ICDR) Regulations, 2018 and list of allottees as mentioned in below annexures. (Details attached in Annexure - A) Details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure-B. The meeting concluded at 6.30 p.m. This is for the information and records of the Exchange, please Thanking you. Yours faithfully, For Godavari Drugs Limited Venkatesh Achanta Company Secretary & Compliance Officer Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.com CIN:L24230TG1987PLC008016 GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com Annexure - A List of Proposed Allottees S No. Name of the Proposed Allottee Equity Shares to be Allotted upon conversion of Warrants Promoter Category 1. Ghanshyam Jaju 60,000 2. Kamala Jaju 1,00,000 3. Mohit Jaju 1,33,355 4. Priyanka Jaju 33,334 5. Ieshir Jaju 66,667 6. Mukund Kakani 1,56,334 7. Sushma Kakani 1,41,000 8. Tanushree Kakani 46,000 9. Aksheit Kakani 50,000 Total 7,86,690 Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.com CIN:L24230TG1987PLC008016 GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com ANNEXURE – B Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 S No. Particulars Details 1. Type of securities proposed to be Equity Shares allotted on conversion of fully paid issued (viz. equity shares, Warrants. convertibles etc.); 2. Type of Issuance (further public Preferential allotment, on a private placement basis. Preferential Allotment offering, (Conversion of Warrants into Equity Shares). rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.) 3. Total number of securities Total number of securities allotted – 7,86,690 proposed to be issued or the total Total amount of securities allotted – amount for which the securities Rs.5,25,11,557.5/- (7,86,690 number of shares * Rs. will be issued (approximately) 66.75/- paid per share) 4. Names of the investors As per Annexure - A 5. Post allotment of securities - Post the conversion of warrants into equity shares, outcome of the subscription, issue the paid-up equity share capital of the Company has price / allotted price (in case of increasedfrom Rs. 10,91,41,250/- (Rupees Ten convertibles), number of investors Crores Ninety-One Lakhs Forty-One Thousand Two Hundred and Fifty Only) consisting of 1,09,14,125 (One Crore Nine Lakhs Fourteen Thousand One Hundred and Twenty-Five)Equity Shares of Rs. 10/- (Rupees Ten Only) each to Rs. 11,70,08,150/- (Rupees Eleven Crores Seventy Lakhs Eight Thousand One Hundred and Fifty Only) consisting of 1,17,00,815(One Crore Seventeen Lakhs Eight Hundred and Fifteen) Equity Shares of Rs. 10/- (Rupees Ten Only) each. Allotment of 7,86,690Equity Shares of Face Value of Rs. 10/- each fully paid up upon conversion of Warrants. 6. In case of convertibles - intimation Exercise by conversion of 7,86,690 Warrants on conversion of securities or on into7,86,690fully paid-up Equity Shares. lapse of the tenure of the instrument Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.com CIN:L24230TG1987PLC008016